• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视二肽羧基肽酶抑制剂卡托普利作为泛抗原生动物药物的来源。

Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents.

机构信息

Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada.

Schools of Biology and Chemistry, Biomedical Sciences Research Complex, University of St. Andrews, St. Andrews, Fife, Scotland KY16 9ST, UK.

出版信息

Bioorg Med Chem Lett. 2024 Sep 15;110:129883. doi: 10.1016/j.bmcl.2024.129883. Epub 2024 Jul 14.

DOI:10.1016/j.bmcl.2024.129883
PMID:39013490
Abstract

The protozoan parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are responsible for continued propagation of neglected tropical diseases such as African sleeping sickness, Chagas disease and leishmaniasis respectively. Following a report that captopril targets Leishmania donovani dipeptidyl carboxypeptidase, a series of simple proline amides and captopril analogues were synthesized and found to exhibit 1-2 μM in vitro inhibition and selectivity against Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. The results were corroborated with computational docking studies. Arguably, the synthetic proline amides represent the structurally simplest examples of in vitro pan antiprotozoal compounds.

摘要

原生动物寄生虫布氏锥虫、克氏锥虫和利什曼原虫分别导致非洲昏睡病、恰加斯病和利什曼病等被忽视热带病的持续传播。有报道称卡托普利可靶向利什曼原虫二肽基羧肽酶,随后合成了一系列简单的脯氨酸酰胺和卡托普利类似物,并发现它们对布氏锥虫、克氏锥虫和利什曼原虫均具有 1-2 μM 的体外抑制作用和选择性。计算对接研究结果证实了这一点。可以说,这些合成的脯氨酸酰胺代表了体外泛抗原生动物化合物的结构最简单的例子。

相似文献

1
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents.重新审视二肽羧基肽酶抑制剂卡托普利作为泛抗原生动物药物的来源。
Bioorg Med Chem Lett. 2024 Sep 15;110:129883. doi: 10.1016/j.bmcl.2024.129883. Epub 2024 Jul 14.
2
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
3
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.基于多组分反应的具有多锥虫活性的三环杂环喹啉的合成及生物学评价
Eur J Med Chem. 2015 Nov 13;105:120-37. doi: 10.1016/j.ejmech.2015.10.007. Epub 2015 Oct 19.
4
The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.磺胺衍生物在治疗包括克氏锥虫、布氏锥虫和利什曼原虫属等锥虫原生动物寄生虫中的应用。
Med Chem. 2020;16(1):24-38. doi: 10.2174/1573406415666190620141109.
5
Novel quinoline derivatives with broad-spectrum antiprotozoal activities.具有广谱抗原生动物活性的新型喹啉衍生物。
Arch Pharm (Weinheim). 2024 Jun;357(6):e2300319. doi: 10.1002/ardp.202300319. Epub 2024 Feb 23.
6
Anilinoquinoline based inhibitors of trypanosomatid proliferation.基于吖啶酮的利什曼原虫增殖抑制剂。
PLoS Negl Trop Dis. 2018 Nov 26;12(11):e0006834. doi: 10.1371/journal.pntd.0006834. eCollection 2018 Nov.
7
Parasitology. Drugs to combat tropical protozoan parasites.寄生虫学。用于对抗热带原生动物寄生虫的药物。
Science. 2002 Jul 19;297(5580):343-4. doi: 10.1126/science.1073126.
8
Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.(2,2':6',2''-三联吡啶)铂(II)配合物对杜氏利什曼原虫、克氏锥虫和布氏锥虫的细胞毒性。
J Med Chem. 1999 Mar 25;42(6):999-1006. doi: 10.1021/jm981074c.
9
Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis.托烷卤代衍生物抗疟疾、昏睡病、恰加斯病和利什曼病的合成及体外评价
Med Chem. 2014;10(8):753-8. doi: 10.2174/1573406410666140507095430.
10
The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.重新审视动基体化疗:现有药物、最新进展及未来展望。
Curr Med Chem. 2010;17(33):4027-51. doi: 10.2174/092986710793205345.